Synthetic small interfering RNAs(siRNAs)can inhibit expression of disease-causing genes through post-transcriptional gene silencing mediated by the endogenous RNA interference(RNAi)pathway[1].However,serum instability,off-target effects,immunostimulatory activity,and poor delivery into cells are the main barriers to this application.Especially,efficient delivery to target cells or organs remains a challenge.